Skip to main content
. 2023 May 31;15(11):2999. doi: 10.3390/cancers15112999

Table 1.

Atomic bomb survivors (n.s. = not specified).

Reference Study Population (Location) Sample Size Type of Exposure Age at Exposure Brain Dose Outcome Age at Outcome Measurement
Wood, Johnson
et al., 1967 [4]
atomic bomb survivors (Japan) 183 γ-rays and neutrons in-utero ≤4 Gy small head size,
mental retardation
n.s.
Otake, Schull; 1984 [2] atomic bomb survivors (Japan) n.s. γ-rays and neutrons in-utero ≤4 Gy forebrain damage,
mental retardation
n.s.
Schull, Otake; 1986 [3] atomic bomb survivors (Japan) n.s. γ-rays and neutrons in-utero ≤4 Gy mental retardation n.s.
Otake, Schull; 1991 [9] atomic bomb survivors (Japan) 1673 γ-rays and neutrons in-utero 0.6–1.4 Gy IQ decline, lower
school performance
10–11 years
Yoshimaru, Otake et al., 1991 [8] atomic bomb survivors (Japan) 929 γ-rays and neutrons in-utero ≤4 Gy lower school performance n.s.
Ikenoue, Ikeda
et al., 1993 [6]
atomic bomb survivors (Japan) 929 γ-rays and neutrons in-utero ≤4 Gy lower school performance n.s.
Otake, Schull; 1993 [7] atomic bomb survivors (Japan) 1473 γ-rays and neutrons in-utero ≤4 Gy small head size,
mental retardation
9–19 years
Yoshimaru, Otake et al., 1995 [8] atomic bomb survivors (Japan) 888 γ-rays and neutrons in-utero ≤4 Gy IQ decline,
mental retardation
15–16 years
Yamada, Sasaki
et al., 2002 [10]
atomic bomb survivors (Japan) 3113 γ-rays and neutrons ≥13 years ≤4 Gy no neurocognitive
dysfunction
adulthood
Yamada, Kasagi
et al., 2009 [12]
atomic bomb survivors (Japan) 2286 γ-rays and neutrons ≥13 years ≤4 Gy no increased risk
of neurodegeneration
≥60 years
Yamada, Landes
et al., 2016 [14]
atomic bomb survivors (Japan) 1844 γ-rays and neutrons ≥13 years ≤4 Gy no increased risk
of neurodegeneration
60–80 years
Yamada, Kato
et al., 2021 [13]
atomic bomb survivors (Japan) 303 γ-rays and neutrons in-utero ≤4 Gy no increased risk
of neurodegeneration
65–70 years
Ishihara, Kato
et al., 2022 [11]
atomic bomb survivors (Japan) 469 γ-rays and neutrons ≤12 years ≤4 Gy no increased risk
of neurodegeneration
≥70 years